Pardo Geoffrey B 4
4 · SHOULDER INNOVATIONS, INC. · Filed Aug 5, 2025
Insider Transaction Report
Form 4
Pardo Geoffrey B
Director10% Owner
Transactions
- Purchase
Common Stock
2025-08-01$15.00/sh+100,000$1,500,000→ 2,380,482 total(indirect: See Footnote) - Award
Common Stock
2025-08-01+7,666→ 7,666 total - Conversion
Common Stock
2025-08-01+2,280,482→ 2,280,482 total(indirect: See Footnote) - Conversion
Series D Convertible Preferred Stock
2025-08-01−33,259,424→ 0 total(indirect: See Footnote)→ Common Stock (1,743,156 underlying) - Conversion
Series E Convertible Preferred Stock
2025-08-01−10,252,188→ 0 total(indirect: See Footnote)→ Common Stock (537,326 underlying)
Footnotes (3)
- [F1]Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis.
- [F2]Held directly by Cooperatieve Gilde Healthcare V U.A. ("Gilde"). Gilde Healthcare V Management B.V. is the managing director of Gilde and has sole voting and dispositive power with respect to the shares held by Gilde. Gilde Healthcare V Management B.V. is owned by Gilde Healthcare Holding B.V. and managed by Edwin de Graaf and Pieter van der Meer. Geoff Pardo is a partner at Gilde and may be deemed to share voting and dispositive power with respect to the shares held of record by Gilde. Mr. Pardo disclaims beneficial ownership of such holdings, except to the extent of his pecuniary interest in the shares.
- [F3]Represents an award of restricted stock units ("RSUs"). The RSUs will vest on the earlier of the date of the annual meeting of stockholders to be held in 2026 or August 1, 2026. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.